RTI BIOLOGICS HONORED WITH BIOFLORIDA’S 2009 GURY COMPANY OF THE YEAR AWARD             
Honored by BioFlorida as Pioneer in the Life Science Industry

 

ALACHUA, Fla. (Nov. 12, 2009) – RTI Biologics Inc. (RTI) (Nasdaq: RTIX), the Florida-based processor of orthopedic, dental, hernia and other biologic implants, was awarded the 2009 Gury Company of the Year Award at the 12th Annual BioFlorida Annnual Conference.

 

RTI received the award for achieving significant technology advancements, product development milestones and making substantial contributions to the advancement of Florida’s bioscience industry.

 

“Being recognized by BioFlorida for the Gury Company of the Year Award is a wonderful honor for RTI," said Brian K. Hutchison, chairman and CEO for RTI. “Since spinning out of the University of Florida many years ago, RTI has had the opportunity to achieve significant growth and to make a very real impact on biologics. We are committed to continued growth as the use of biologics in surgery becomes more and more prevalent. With the support of our legislators and the collaboration of the biotechnology industry, the state of Florida is growing as a knowledge economy, and we look forward to many more successes in this industry in the future.”

 

The Gury Company of the Year Award recognizes businesses for their contributions to upholding the legacy of one of the founding members and a past chairman of BioFlorida, David Gury.  Gury has created and managed biotechnology companies that foster the industry’s growth and continue to serve as an advocate and leader in Florida’s bioscience community.

RTI was selected for the award by a panel of industry leaders.

 

About BioFlorida
BioFlorida is Florida’s statewide trade association for the bioscience industry providing advocacy, business development and communications services for more than 200 member companies. Our mission is to be the voice of the bioscience industry and the advocate for our member organizations. Bringing knowledge and resources to Florida’s bioscience community, BioFlorida supports the health, agricultural and energy sectors of biotechnology as well as the pharmaceutical and medical technology fields.

 

About RTI Biologics Inc.
RTI Biologics, Inc. is a leading provider of sterile biological implants for surgeries around the world with a commitment to advancing science, safety and innovation. RTI prepares human donated tissue and bovine tissue for transplantation through extensive testing and screening, precision shaping and proprietary, validated sterilization processes. These allograft and xenograft implants are used in orthopedic, dental, hernia and other specialty surgeries.

 

RTI’s innovations continuously raise the bar of science and safety for biologics – from being the first company to offer precision-tooled bone implants and assembled technology to maximize each gift of donation, to inventing validated sterilization processes that include viral inactivation steps. Two such processes – the BioCleanse® Tissue Sterilization Process and the Tutoplast® Tissue Sterilization Process – have a combined record of more than two million implants distributed with zero incidence of allograft-associated infection. These processes have been validated by tissue type to penetrate tissue, inactivate or remove viruses and a wide range of organisms using worst-case testing and maintain tissue biocompatibility and functionality.

 

RTI’s worldwide corporate headquarters are located in Alachua, Fla., with international locations in Neunkirchen, Germany, and Aix-en-Provence, France. The company is accredited in the U.S. by the American Association of Tissue Banks.

 

Contact: Wendy Crites Wacker, APR
Corporate Communications
wwacker@rtix.com
Phone (386) 418-8888